Samheiti: Evrólímus, Afinitor; Certican; Zortress
Sýnataka, geymsla og sýnasending
Gerđ sýnis : EDTA-blóđ. Sýni tekiđ í glas međ fjólubláum tappa án gels (svört miđja) Litakóđi samkvćmt Greiner
Sýni tekiđ fyrir lyfjagjöf
Min 2,7 mL. EKKI skilja niđur !
Geymsla sýnis: Kćlir Sýni geymist viku viđ stofuhita.
Sýnasending: Hrađsending til útlanda. Sent helst samdćgurs
Fróđleikur: Everolimus is an antineoplastic chemotherapy drug. This medication is classified as an "mTOR kinase (also known as the mammalian target of rapamycin) inhibitor."
What Everolimus Is Used For:*
|(The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein kinase, controls cell growth|
in response to nutrients and growth factors and is frequently deregulated in cancer)
Everolimus has also been used in heart, liver or kidney transplantation, Waldenstrom macroglobulinemia, and certain carcinoid tumors.
- Breast Cancer: Treatment (in combination with exemestane) of advanced breast cancer in postmenopausal women following failure of letrozole or anastrozole therapy.
- Neuroendocrine Tumors (NET): Treatment of certain advanced neuroendocrine tumors of pancreatic, gastrointestinal, or lung origin.
- Renal Cell Carcinoma (RCC): Treatment of advanced renal cell carcinoma after failure of treatment with sunitinib or sorafenib.